Alopecia Areata: From Diagnosis to Treatment
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Dermatology".
Deadline for manuscript submissions: closed (5 May 2024) | Viewed by 236
Special Issue Editors
Interests: trichology; trichoscopy; hair; alopecia areata; acne vulgaris; scalp psoriasis; oncodermatology
Interests: tricology; tricoscopy; hair loss; alopecia areata; seborrheic dermatitis; androgenetic alopecia; psoriasis
2. Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy
Interests: alopecia; hair loss; nail; hair; alopecia areata; cicatricial alopecia; nail tumors; onychomycosis; scaling
Special Issue Information
Dear Colleagues,
Alopecia areata (AA) has been receiving increasing scientific attention in recent years. The reports of AA onset and reacutization after COVID-19 infection and vaccination shed new light on the pathogenesis of this disease and its possible triggers and worsening factors. Moreover, the introduction of Janus kinase (JAK) as a new effective treatment paved the way for a new therapeutic era for a disease whose therapies were often off-label and not always satisfactory. Nevertheless, this is just the beginning and there is still a lot to know about the mechanisms underlying AA, about how new therapies work and how they can give the best results. In this view, old and new diagnostic tools will be crucial for identifying the different pathogenic moments and for monitoring therapeutic progress.
In this Special Issue, we welcome authors to submit papers on any aspect of alopecia areata in order to be part of a new chapter of the story of this disease and to help improve the quality of life of affected patients.
Dr. Gemma Caro
Prof. Dr. Alfredo Rossi
Dr. Michela Starace
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- alopecia areata
- alopecia totalis
- alopecia universalis
- JAK inhibitors
- trichoscopy
- JAK-STAT signaling pathway
- quality of life
